EICHORCondition: Moderate to Severe Genital Psoriasis · Sponsor: Sun Pharmaceutical Industries Limited
Phase 3 study to evaluate the efficacy and safety of subcutaneous tildrakizumab in subjects with moderate to severe genital psoriasis.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Smary Cures Clinical Research | Anaheim, California, United States | — |
| California Dermatology & Clinical Research Institute | Encinitas, California, United States | — |
| T. Joseph Raoof MD, Inc./Encino Research Center | Encino, California, United States | — |
| Center for Dermatology Clinical Research, Inc | Fremont, California, United States | — |
| Dermatology Research Associates | Los Angeles, California, United States | — |
| LA Universal Research Center Inc, Suite 1 | Los Angeles, California, United States | — |
| Amicis Research Center | Northridge, California, United States | — |
| Therapeutics Clinical Research | San Diego, California, United States | — |
| Dermatology Institute and Skin Care Center, Inc. DBA Clinical Science Institute | Santa Monica, California, United States | — |
| Paradigm Clinical Research | Wheat Ridge, Colorado, United States | — |
| Coral Gables Dermatology & Aesthetics | Coral Gables, Florida, United States | — |
| Florida Academic Centers Research and Education, LLC | Coral Gables, Florida, United States | — |
+ 44 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06611163